GB9902041D0 - Method for increasing muscle mass in animals - Google Patents

Method for increasing muscle mass in animals

Info

Publication number
GB9902041D0
GB9902041D0 GBGB9902041.4A GB9902041A GB9902041D0 GB 9902041 D0 GB9902041 D0 GB 9902041D0 GB 9902041 A GB9902041 A GB 9902041A GB 9902041 D0 GB9902041 D0 GB 9902041D0
Authority
GB
United Kingdom
Prior art keywords
animals
muscle mass
increasing muscle
increasing
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9902041.4A
Other versions
GB2333706A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9902041D0 publication Critical patent/GB9902041D0/en
Publication of GB2333706A publication Critical patent/GB2333706A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
GB9902041A 1998-02-02 1999-01-29 Method for increasing muscle mass in animals Withdrawn GB2333706A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7343898P 1998-02-02 1998-02-02

Publications (2)

Publication Number Publication Date
GB9902041D0 true GB9902041D0 (en) 1999-03-17
GB2333706A GB2333706A (en) 1999-08-04

Family

ID=22113671

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9902041A Withdrawn GB2333706A (en) 1998-02-02 1999-01-29 Method for increasing muscle mass in animals

Country Status (1)

Country Link
GB (1) GB2333706A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778470B2 (en) * 1999-07-20 2004-12-09 Pharmexa A/S Method for down-regulating GDF-8 activity
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
CU23077A1 (en) * 2000-12-06 2005-08-17 Centro Inmunologia Molecular VACCINE COMPOSITION CONTAINING TRANSFORMING GROWTH FACTOR (TGF-ALFA). ITS USE IN MALIGNAL DISEASE THERAPY
US7037501B2 (en) 2001-01-04 2006-05-02 Regents Of The University Of Minnesota Myostatin immnoconjugate
MEP57508A (en) 2002-12-20 2011-05-10 Amgen Inc Binding agents which inhibit myostatin
PL2336147T3 (en) 2003-12-17 2015-01-30 Janssen Alzheimer Immunotherap A beta immunogenic peptide carrier conjugates and methods of producing same
MXPA06007514A (en) * 2003-12-31 2006-08-31 Schering Plough Ltd Neutralizing epitope-based growth enhancing vaccine.
EA014112B1 (en) * 2004-03-23 2010-10-29 Эли Лилли Энд Компани Anti-myostatin monoclonal antibodies and methods of using thereof
TW200634156A (en) * 2004-12-30 2006-10-01 Schering Plough Ltd Neutralizing epitope-based growth enhancing vaccine
CN101277976B (en) 2005-10-06 2012-04-11 伊莱利利公司 Anti-myostatin antibodies
UA92504C2 (en) 2005-10-12 2010-11-10 Эли Лилли Энд Компани Anti-myostatin monoclonal antibody
BRPI0716249A2 (en) 2006-09-05 2013-09-03 Lilly Co Eli antimiostatin antibodies
AU2021207701A1 (en) * 2020-01-17 2022-09-15 Bill & Melinda Gates Foundation Multivalent Streptococcus vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6274298A (en) * 1997-02-05 1998-08-25 Johns Hopkins University School Of Medicine, The Growth differentiation factor-8
DE69841139D1 (en) * 1997-07-14 2009-10-22 Univ Liege MUTATIONS IN MYOSTATINGEN INCREASE MUSCLE MASS IN MAMMALS
AU8666398A (en) * 1997-08-01 1999-02-22 Johns Hopkins University School Of Medicine, The Methods to identify growth differentiation factor (gdf) receptors

Also Published As

Publication number Publication date
GB2333706A (en) 1999-08-04

Similar Documents

Publication Publication Date Title
GB2342743B (en) Verification method
HK1102476A1 (en) Exercise apparatus
GB9809414D0 (en) Method
GB9902041D0 (en) Method for increasing muscle mass in animals
GB2339395A8 (en) Exercise apparatus
GB9809776D0 (en) Method
GB2341806B (en) An exercise apparatus
GB9810722D0 (en) Method
GB9819764D0 (en) Method
GB9814055D0 (en) Method
GB9802475D0 (en) Method
GB9819769D0 (en) Method
GB9817266D0 (en) Method
IL133671A0 (en) Exercise method
HUP0101730A3 (en) Method for preparing and using b-starch
GB9809780D0 (en) Method
GB9809782D0 (en) Method
GB9818290D0 (en) Exercise apparatus
GB9906464D0 (en) Improvements in animal excercising or training apparatus
GB9804355D0 (en) Method
CA82783S (en) Exercise apparatus
GB9800922D0 (en) Improvements in fishing apparatus
IL124408A0 (en) Exercising method and means for strengthning the spinal muscles
IL127035A0 (en) Exercise apparatus
GB9814362D0 (en) Exercise apparatus

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)